This 2020 electron microscope image provided by the National Institute of Allergy and Infectious Diseases - Rocky Mountain Laboratories shows SARS-CoV-2 virus particles which cause COVID-19, isolated from a patient in the U.S., emerging from the surface of cells cultured in a lab. According to a study released in The Lancet Global Health on Wednesday, Oct. 27, 2021, Fluvoxamine, a cheap antidepressant, reduced the need for hospitalization among high-risk adults with COVID-19. (NIAID-RML via AP)
By Carla K. Johnson
A cheap antidepressant reduced the need for hospitalization among high-risk adults with COVID-19 in a study hunting for existing drugs that could be repurposed to treat coronavirus.
Researchers tested the pill used for depression and obsessive-compulsive disorder because it was known to reduce inflammation and looked promising in smaller studies.
They've shared the results with the U.S. National Institutes of Health, which publishes treatment guidelines, and they hope for a World Health Organization recommendation.
“If WHO recommends this, you will see it widely taken up,” said study co-author Dr. Edward Mills of McMaster University in Hamilton, Ontario, adding that many poor nations have the drug readily available. “We hope it will lead to a lot of lives saved.”
The pill, called fluvoxamine, would cost $4 for a course of COVID-19 treatment. By comparison, antibody IV treatments cost about $2,000 and Merck's experimental antiviral pill for COVID-19 is about $700 per course. Some experts predict various treatments eventually will be used in combination to fight the coronavirus.
Researchers tested the antidepressant in nearly 1,500 Brazilians recently infected with coronavirus who were at risk of severe illness because of other health problems, such as diabetes. About half took the antidepressant at home for 10 days, the rest got dummy pills. They were tracked for four weeks to see who landed in the hospital or spent extended time in an emergency room when hospitals were full.
In the group that took the drug, 11% needed hospitalization or an extended ER stay, compared to 16% of those on dummy pills.
The results, published Wednesday in the journal Lancet Global Health, were so strong that independent experts monitoring the study recommended stopping it early because the results were clear.
Questions remain about the best dosing, whether lower risk patients might also benefit and whether the pill should be combined with other treatments.
The larger project looked at eight existing drugs to see if they could work against the pandemic virus. The project is still testing a hepatitis drug, but all the others — including metformin, hydroxychloroquine and ivermectin — haven't panned out.
The cheap generic and Merck's COVID-19 pill work in different ways and “may be complementary,” said Dr. Paul Sax of Brigham and Women’s Hospital and Harvard Medical School, who was not involved in the study. Earlier this month, Merck asked regulators in the U.S. and Europe to authorize its antiviral pill.
___
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.
Space travel is growing rapidly, and one billionaire businessman has purchased three SpaceX flights in order to push the industry forward. The Polaris Dawn, the first of three flights, will launch later this year, and its crew will conduct the first commercial spacewalk after they've reached the highest orbit in over 50 years. Jared Isaacman, Polaris Program Mission Commander and Founder & CEO of Shift4, joins Closing Bell to discuss the Polaris program's mission, when the first launch will happen and what it will entail, balancing his business with space exploration efforts, charitable efforts with St. Jude Children's Research Hospital, and more.
The most recent quarterly report from American Clean Power reveals the U.S. surpassed more than 200 gigawatts of total operating utility-scale clean power capacity in 2021. While it is a great milestone, significant policy issues have continued to slow growth for the industry and threaten our country's ability to meet emissions goals. John Hensley, VP for Research and Analytics at American Clean Power, joined Cheddar News to discuss more.
Cann, a cannabis-infused beverage company, announced today a $27 million Series A funding round from existing investors like Imaginary Ventures and a roster of new celebrity investors including Nina Dobrev, Adam Devine, Zoey Deutch, Jordan Cooper, Sara Foster, and Rosario Dawson. Cann is also announcing its first international expansion with the brand's launch in Canada. Jake Bullock, co-founder and CEO of Cann, joins Cheddar News' Closing Bell to discuss.
By 2050, nuclear power share of total energy consumption will dip to just 3.7% down from the already measly 4.5% it is today, according to the U. S. Energy Information Administration. However, a group of world powers including the U.S. and Japan is looking to reverse the trend. John Kotek, SVP of Policy Development and Public Affairs at the Nuclear Energy Institute, joined Cheddar News to discuss.
Scientists say the fossil of a 170-million-year-old pterosaur, billed as the world’s best-preserved skeleton of the prehistoric winged reptile, has been found on the Isle of Skye in Scotland.
Equip is a virtual treatment platform for eating disorders, and recently raised $58 million in a Series B round led by The Chernin Group. The company aims to revolutionize treatment for eating disorders by delivering virtual care teams and clinical expertise directly to families' homes. Equip says the need for its platform has only been exacerbated by the COVID-19 pandemic. The National Eating Disorder Association's helpline has had a 107% increase in contacts since the start of the pandemic. Kristina Saffran, CEO and co-founder of Equip, joins Cheddar News' Closing Bell to discuss.
Tonga's main internet connection to the rest of the world has finally been restored more than five weeks after a huge volcanic eruption and tsunami severed a crucial undersea cable.
Hank the Tank strikes again. The 500-pound black bear that has damaged more than 30 properties around Lake Tahoe last week broke into yet another home in its endless quest for a quick meal.
